(Q70176098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

N Zaias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

D Drachman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

language of work or name

English

0 references

publication date

1 December 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

912-919

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

Griseofulvin for the systemic treatment of dermatomycoses

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

Clinical antifungal activity of thiabendazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

Ketoconazole — a new broad spectrum orally active antimycotic

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

Oral Therapy with Ketoconazole for Dermatophyte Infections Unresponsive to Griseofulvin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

Therapeutic Evaluation of Ketoconazole in Patients with Coccidioidomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

Treatment of Chronic Mucocutaneous Candidosis with Ketoconazole: Preliminary Results of a Controlled, Double-Blind Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

Ketoconazole: A New Drug for the Treatment of Paracoccidioidomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

Toxic hepatis during ketoconazole treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

Gynecomastia with ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

The Activity of Ketoconazole in the Treatment of Onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2883%2970208-2

7 January 2021

10.1016/S0190-9622(83)70208-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6315789%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference